Junior Biotech is having a tough year in contrast to many other market segments -
S&P500 is up 25% YTD as of Friday
Nasdaq Biotech Index is up just 4%
Nasdaq Junior Biotech Index is DOWN 28% YTD
As a result many of the already beaten down small and microcap biotechs are being sold into year end for tax purposes .... so they may be setting up for a nice bounce in January. I'll be doing some bottom fishing in the coming weeks ....